Glial scar inhibition

The glial scar is a multicellular structure that forms at sites of CNS injury, comprised primarily of reactive astrocytes, microglia, and NG2 glia that isolate the lesion core and produce extracellular matrix proteins. While the scar acts as a barrier to limit the spread of inflammation and facilitate healing, it also impedes axonal regeneration and functional recovery, in part by producing inhibitory molecules that block neural regrowth. "Glial scar inhibition" thus refers to interventions aiming to reduce or modify glial scar formation—either by enzymatic degradation of matrix components such as proteoglycans, suppression of astrocyte activation, or modulation of key signaling pathways—in order to promote neural regeneration and functional recovery after CNS injury. However, therapeutic inhibition of the glial scar must balance its beneficial role in containing tissue damage and promoting healing with its detrimental effects on neural repair[1][3][4][5][6][7].

Other names

Scar formation inhibitionAstrogliosis inhibitionInhibition of glial responseInhibition of CNS scarring

Enzymatic degradation of extracellular matrix components (e.g., chondroitin sulfate proteoglycans); Modulation of signaling pathways in reactive astrocytes (e.g., STAT3, SMAD, TGFβ); Anti-inflammatory or immunomodulatory mechanisms